1,027 material Form 8-K filings that 835 companies we cover made with the SEC in February 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Middlesex Water reported 2024 net income of $44.4 million and diluted EPS of $2.47, up from $31.5 million and $1.76 in 2023. Revenue rose $25.6 million to $191.9 million, driven mainly by a New Jersey base rate increase and higher weather-driven customer demand, which points to stronger earnings for shareholders.
2024 net income of $44.4 million, up $12.8 million from 2023; diluted EPS of $2.47 versus $1.76
2024 revenues of $191.9 million, up $25.6 million from $166.3 million; Middlesex System revenues rose $19.9 million on the base rate increase approved in March 2024
Fourth quarter 2024 net income of $8.8 million and diluted EPS of $0.49, versus $5.8 million and $0.32 in the fourth quarter of 2023
Board declared a first quarter 2025 dividend of $0.34 per share, payable March 3, 2025; Ocean View water utility asset purchase for about $4.6 million expected to close by April 2025
MasTec reported fourth quarter and full-year 2024 results on February 27, 2025, with revenue and GAAP net income both higher than in 2023. The company also issued initial 2025 guidance, including $13.45 billion in revenue and GAAP net income of $327 million to $366 million, and expects a GAAP net loss of $1 million in the first quarter of 2025.
Q4 2024 revenue was $3.4 billion, up from $3.3 billion; GAAP net income was $84.7 million, versus $1.2 million in Q4 2023.
Full-year 2024 GAAP net income was $199.4 million, or $2.06 per diluted share, compared with a net loss of $47.3 million in 2023.
2025 guidance: revenue of $13.45 billion, GAAP diluted EPS of $3.75 to $4.24, and adjusted EBITDA of $1.10 billion to $1.15 billion.
Estimated 18-month backlog reached a record $14.3 billion at December 31, 2024; net debt leverage ratio was 1.8x.
Tidewater reported fourth-quarter 2024 revenue of $345.1 million, up from $302.7 million a year earlier, while quarterly net income of $36.9 million ($0.70 per diluted share) was roughly flat against $37.7 million ($0.70) in the prior-year quarter. The company also initiated 2025 revenue guidance of $1.32 billion to $1.38 billion and approved a new share repurchase program of up to $90.3 million, which management said is the maximum permitted under its existing debt agreements.
Q4 2024 revenue of $345.1 million, compared with $302.7 million for Q4 2023
Q4 2024 net income of $36.9 million ($0.70 per diluted share), compared with $37.7 million ($0.70) for Q4 2023
Full-year 2024 net income of $180.7 million ($3.40 per diluted share), up 85.9% from 2023
2025 guidance: revenue of $1.32 billion to $1.38 billion and gross margin of 48% to 50%; new buyback authorization of $90.3 million
Arcosa reported fourth quarter 2024 revenue up 14% to $666.2 million, helped by the $1.2 billion Stavola acquisition completed October 1, 2024, but posted a net loss of $7.7 million versus net income of $27.1 million a year earlier. Acquisition-related expenses of $15.6 million and higher interest expense weighed on results, while Adjusted EBITDA rose 52% to $128.3 million. The company guided to 2025 revenues of $2.8 billion to $3.0 billion and Adjusted EBITDA of $545 million to $595 million, with GAAP profit trends and guidance pointing in different directions for shareholders.
Q4 2024 revenue was $666.2 million, up 14% from $582.2 million; net loss was $7.7 million, or $0.16 per diluted share, versus net income of $27.1 million, or $0.56 per share, in Q4 2023.
Q4 Adjusted EBITDA rose 52% to $128.3 million; Adjusted Diluted EPS fell 32% to $0.46 from $0.68.
Full year 2025 guidance: consolidated revenues of $2.8 billion to $3.0 billion and Adjusted EBITDA of $545 million to $595 million.
Q4 free cash flow was $199.2 million; year-end net debt to Adjusted EBITDA was 2.9x, down from 3.4x at the end of the third quarter.
Assured Guaranty reported fourth quarter 2024 net income attributable to the company of $18 million, or $0.35 per diluted share, down from $376 million, or $6.40 per share, a year earlier. The prior-year quarter included a $208 million benefit from tax law changes, and full-year 2024 net income fell to $376 million, or $6.87 per share, from $739 million, or $12.30 per share. For shareholders, the decline in reported earnings is large, though the company also repurchased $502 million of shares in 2024.
Q4 2024 adjusted operating income was $66 million, or $1.27 per share, versus $338 million, or $5.75 per share, in Q4 2023.
Full-year 2024 adjusted operating income was $389 million, or $7.10 per share, versus $648 million, or $10.78 per share, in 2023.
Q4 2024 total revenues were $156 million, versus $327 million in Q4 2023; full-year revenues were $872 million, versus $1,373 million.
As of February 27, 2025, the company was authorized to buy back about $276 million of its common shares, and it expects a gain of about $103 million in Q1 2025 from the LBIE litigation.
HP reported fiscal first-quarter revenue of $13.5 billion, up 2.4% from a year earlier, while GAAP diluted EPS fell to $0.59 from $0.62. HP also approved an expansion of its restructuring plan, adding about $0.3 billion in annualized savings and about $150 million in charges, with 1,000 to 2,000 additional gross workforce reductions, and it held its fiscal 2025 outlook.
Q1 fiscal 2025 net revenue $13.5 billion, up 2.4%; GAAP diluted EPS $0.59 versus $0.62, within the $0.57 to $0.63 outlook
Non-GAAP diluted EPS $0.74 versus $0.81 a year earlier, within the $0.70 to $0.76 outlook
Restructuring amendment adds about $0.3 billion in fiscal 2025 savings, bringing the total to about $1.9 billion, with about $150 million in additional charges
Incremental gross workforce reductions of about 1,000 to 2,000 employees, varying by country; fiscal 2025 non-GAAP EPS outlook of $3.45 to $3.75 held
American Healthcare REIT reported fourth-quarter and full-year 2024 results on February 27, 2025, and issued full-year 2025 guidance. The fourth-quarter GAAP net loss per diluted share narrowed to $(0.21) from $(0.42) a year earlier, and normalized FFO per diluted share rose to $0.40 from $0.38, while full-year normalized FFO was $1.41 versus $1.40 in 2023. For 2025, the company expects normalized FFO of $1.56 to $1.60 per diluted share and total portfolio same-store NOI growth of 7.0% to 10.0%.
Q4 2024 GAAP net loss attributable to controlling interest was $(31.8) million, or $(0.21) per diluted share, versus $(27.4) million, or $(0.42), in Q4 2023.
Full-year 2024 normalized FFO was $1.41 per diluted share; total portfolio same-store NOI grew 17.7%.
2025 guidance: normalized FFO of $1.56 to $1.60 per diluted share and net income of $0.26 to $0.30 per diluted share, versus a 2024 net loss of $(0.29).
Company raised about $1.36 billion of gross equity in 2024, including $120.2 million through its at-the-market program in Q4.
Solventum reported fourth-quarter 2024 sales up 1.9% to $2.074 billion, but GAAP diluted EPS fell to $0.17 from $1.57 a year earlier, and adjusted EPS fell to $1.41 from $2.17. The company also introduced 2025 guidance for organic sales growth, adjusted EPS and free cash flow, but said the guidance still includes the Purification and Filtration segment it agreed to sell and will be updated after that deal closes.
Q4 2024 sales were $2.074 billion, up 1.9%; organic sales rose 2.3%
GAAP operating income was $136 million versus $406 million a year earlier; adjusted operating margin was 20.4% versus 25.9%
2025 guidance: organic sales growth of 1.0% to 2.0%, adjusted EPS of $5.45 to $5.65, free cash flow of $450 million to $550 million
Guidance includes Purification and Filtration, which Solventum announced it would sell on February 25, 2025
DoubleVerify reported fourth-quarter 2024 revenue of $190.6 million, up 11% from a year earlier, but net income fell to $23.4 million from $33.1 million. The company also agreed to acquire Rockerbox for $85 million in cash and guided first-quarter 2025 revenue to $151 million to $155 million, with full-year 2025 revenue growth of about 10%. Shareholders see revenue growth alongside lower profit, plus a new acquisition that adds to the company's spending.
Q4 2024 revenue of $190.6 million, up 11%; Q4 net income of $23.4 million versus $33.1 million in Q4 2023
Full-year 2024 revenue of $656.8 million, up 15%; full-year net income of $56.2 million versus $71.5 million in 2023
Q1 2025 revenue guidance of $151 million to $155 million; full-year 2025 revenue growth of approximately 10%
Agreed to acquire Rockerbox, Inc. for $85 million in cash, subject to customary adjustments, announced February 26, 2025
Acadia Healthcare reported fourth-quarter 2024 revenue of $774.2 million, up 4.2% from a year earlier, but net income attributable to Acadia fell to $32.6 million, or $0.35 per diluted share, from $57.7 million, or $0.63, in the prior-year quarter. The company also issued 2025 guidance, including revenue of $3.3 to $3.4 billion and adjusted EPS of $2.50 to $2.80, and authorized a $300 million share repurchase program.
Q4 2024 revenue $774.2 million, up 4.2%; adjusted EBITDA $153.1 million versus $171.6 million a year earlier
Full-year 2024 revenue $3.15 billion, up 7.7%; net income attributable to Acadia $255.6 million versus a loss of $21.7 million in 2023
2025 guidance: revenue $3.3 to $3.4 billion, adjusted EBITDA $675 to $725 million, adjusted EPS $2.50 to $2.80
Board authorized share repurchases of up to $300 million with no expiration date; conference call scheduled February 28, 2025
Sunrun reported fourth-quarter and full-year 2024 results. Revenue was flat in Q4 and down 10% for the year, and a $3.1 billion non-cash goodwill impairment drove a large GAAP net loss. The company reported Cash Generation of $34.2 million in Q4 and gave 2025 Cash Generation guidance of $200 million to $500 million.
Q4 2024 total revenue was $518.5 million, up $1.9 million, or 0%, from Q4 2023; full-year 2024 revenue was $2.0 billion, down 10%.
Q4 2024 net loss attributable to common stockholders was $2.8 billion, or $12.51 per share, including the $3.1 billion goodwill impairment; non-GAAP net income was $360.9 million, or $1.41 per diluted share.
2025 Cash Generation guidance is $200 million to $500 million for the full year and $40 million to $50 million for Q1 2025.
Edison International reported fourth-quarter 2024 net income of $340 million, or $0.88 per share, down from $378 million, or $0.99 per share, a year earlier. Full-year 2024 GAAP EPS rose to $3.33 from $3.12, and core EPS rose to $4.93 from $4.76. The company revised its 2025 core EPS guidance to $5.94-$6.34, which includes the impact of the TKM settlement, and the filing does not state the prior range.
Q4 2024 core EPS was $1.05, compared with $1.28 a year earlier; core earnings were $405 million versus $490 million.
Full-year 2024 operating revenue was $17.6 billion, up from $16.3 billion in 2023.
TKM settlement approved, authorizing $1.6 billion of cost recovery for pre-AB 1054 wildfire costs.
Quarterly dividend of $0.8275 per share declared, payable April 30, 2025, to holders of record on April 7, 2025.
Mosaic reported fourth quarter and full year 2024 results. Full-year net sales fell 19% to $11.1 billion and net income fell 85% to $175 million, with a $642 million foreign exchange loss weighing on results. Management expects phosphate and potash volumes to recover in 2025 and gave production, sales volume, price and capital expenditure assumptions for the year.
Q4 2024 net income was $169 million, down from $365 million in Q4 2023; Q4 adjusted EBITDA was $594 million versus $646 million
Full-year 2024 adjusted EBITDA was $2.2 billion, down 20% from 2023; full-year diluted EPS was $0.55
Notable items reduced 2024 EPS by $1.43, mainly a $642 million foreign currency transaction loss, partly offset by a $522 million Ma'aden gain
2025 guidance includes potash production of 8.7-9.1 million tonnes and phosphate production of 7.2-7.6 million tonnes, with capital expenditures of $1.2-1.3 billion
Medical Properties Trust reported a fourth-quarter 2024 net loss of $413 million ($0.69 per share) and a full-year net loss of $2.4 billion ($4.02 per share), including about $415 million of impairments and fair market value adjustments tied to Prospect Medical Group and PHP Holdings. Normalized FFO fell to $0.18 per share for the quarter from $0.36 a year earlier and to $0.80 for the year from $1.59. The company said a $2.5 billion senior secured notes offering addresses all debt maturities through 2026.
Q4 2024 net loss of $413 million ($0.69 per share) versus $664 million ($1.11 per share) in Q4 2023
Q4 2024 normalized FFO of $0.18 per share versus $0.36; full-year 2024 normalized FFO of $0.80 versus $1.59
Full-year 2024 net loss of $2.4 billion ($4.02 per share) versus $556 million ($0.93 per share) in 2023
Private offering of more than $2.5 billion of senior secured notes due 2032 at a blended coupon of 7.885%
On February 27, 2025, Viatris reported fourth quarter and full-year 2024 results and issued 2025 guidance. Full-year 2024 total revenues were $14.7 billion, down 5% as reported, and the U.S. GAAP net loss was $634.2 million, compared with net earnings of $54.7 million in 2023. The company guided 2025 total revenues to $13.5 billion to $14.0 billion and adjusted EPS to $2.12 to $2.26, and said an FDA import alert at its Indore facility is expected to reduce 2025 total revenues by about $500 million and adjusted EBITDA by about $385 million.
Full-year 2024 total revenues were $14.7 billion, down 5% as reported; adjusted EPS was $2.65, versus $2.93 in 2023.
U.S. GAAP net loss was $(634.2) million for 2024, compared with net earnings of $54.7 million in 2023.
2025 guidance: total revenues of $13.5 billion to $14.0 billion and adjusted EPS of $2.12 to $2.26.
Indore facility impact is estimated at about $500 million to 2025 total revenues and about $385 million to adjusted EBITDA; the company plans $500 million to $650 million in 2025 share repurchases.
Frontdoor reported full-year 2024 revenue up 4% to $1.84 billion, net income up 37% to $235 million, and diluted earnings per share up 42% to $3.01. For 2025, it projects revenue of $2.0 billion to $2.04 billion and Adjusted EBITDA of $450 million to $475 million, including the 2-10 Home Buyers Warranty acquisition.
Full-year 2024 Adjusted EBITDA rose 28% to $443 million, and gross profit margin expanded 410 basis points to 54%.
Fourth-quarter 2024 revenue rose 5% to $383 million, while net income was flat at $9 million.
The 2025 outlook includes a gross profit margin of 51.5% to 53% and Adjusted EBITDA of $450 million to $475 million.
The company repurchased $160 million of shares in 2024 and will hold a 2025 Investor Day on February 27, 2025.
Installed Building Products reported fourth-quarter 2024 net revenue up 4.1% to a record $750.2 million, with net income up 3.1% to $66.9 million, or $2.39 per diluted share. For the full year, net revenue rose 5.9% to a record $2.9 billion and diluted EPS rose to $9.10 from $8.61, and the Board approved a 6% higher quarterly dividend and a $1.70 annual variable dividend payable March 31, 2025.
Q4 2024 net income $66.9 million, or $2.39 per diluted share, versus $64.9 million, or $2.29, a year earlier
Full-year 2024 net income $256.6 million, or $9.10 per diluted share, versus $8.61 in 2023
Quarterly cash dividend of $0.37 per share and annual variable dividend of $1.70 per share, payable March 31, 2025 to holders of record March 14, 2025
New stock repurchase program of up to $500 million, expiring March 1, 2026
J.M. Smucker reported fiscal third-quarter results for the period ended January 31, 2025, with net sales down 2% to $2.2 billion and a GAAP net loss of $6.22 per diluted share, driven by $794.3 million and $208.2 million noncash impairment charges tied to Sweet Baked Snacks. Adjusted EPS rose 5% to $2.61, and the company raised the low and high ends of its fiscal 2025 adjusted EPS guidance while lowering its net sales growth outlook.
Net sales were $2,186.0 million, down $43.2 million or 2% from the prior-year quarter.
Net loss per diluted share was $6.22, including a $794.3 million goodwill impairment and a $208.2 million trademark impairment.
Adjusted EPS was $2.61, up 5%; free cash flow was $151.3 million versus $249.6 million a year earlier.
Fiscal 2025 adjusted EPS guidance was updated to $9.85 to $10.15 from $9.70 to $10.10; net sales growth guidance is 7.25% versus 7.50% to 8.50% previously.
AAON reported fourth-quarter 2024 net sales down 2.9% to $297.7 million and diluted EPS down 46.4% to $0.30 from $0.56, with AAON Oklahoma sales down 16.1%. Full-year 2024 net sales rose 2.7% to $1.2 billion, backlog ended the year at $867.1 million, up 70.0%, and management expects margins to stay under pressure early in 2025. The Board also authorized up to $100.0 million in open-market share repurchases.
Q4 gross profit fell 30.5% to $77.6 million and operating income fell 53.9% to $29.4 million.
Full-year 2024 net sales rose 2.7% to $1.2 billion, while diluted EPS fell 5.2% to $2.02.
Backlog was $867.1 million at December 31, 2024, up 70.0% from a year earlier.
The Board authorized up to $100.0 million in share repurchases, to be executed based on market conditions.
Macerich reported fourth-quarter 2024 results on February 27, 2025, showing a net loss attributable to the company of $211.2 million, or $0.89 per diluted share, compared with net income of $62.2 million, or $0.29 per share, a year earlier. Total revenues rose to $273.7 million from $238.7 million, but FFO excluding certain items fell to $116.7 million ($0.47 per share) from $127.7 million ($0.57 per share), so shareholders face a weaker quarter on the company's core measures despite higher revenue.
Total revenues were $273.7 million in Q4 2024, up from $238.7 million in Q4 2023.
Net loss attributable to the company was $211.2 million ($0.89 per diluted share), versus net income of $62.2 million ($0.29 per share) a year earlier.
FFO excluding certain items was $116.7 million ($0.47 per share), down from $127.7 million ($0.57 per share).
Same center NOI, excluding lease termination income, fell 0.4% in Q4 2024; portfolio occupancy was 94.1% at December 31, 2024. The quarterly dividend is $0.17 per share, payable March 18, 2025.
PENN Entertainment reported fourth-quarter 2024 revenue of $1,669.0 million, up from $1,395.4 million a year earlier, and a net loss of $133.8 million, narrowed from $358.8 million. The company also said it intends to repurchase at least $350 million of shares in 2025, which matters to shareholders because it signals a large capital return alongside improved results.
Q4 2024 diluted loss per share was $(0.88), compared with $(2.37) in Q4 2023.
Adjusted EBITDA was $165.2 million, compared with a loss of $(39.6) million in the prior-year quarter.
Interactive segment revenue was $275.0 million, compared with $31.5 million a year earlier, including a tax gross-up of $132.8 million.
Full-year 2024 net loss was $313.3 million, compared with $491.4 million in 2023.
First Advantage reported fourth quarter and full year 2024 results, which include costs from its Sterling acquisition, closed October 31, 2024. Full year revenue rose to $860.2 million from $763.8 million, but the company posted a net loss of $110.3 million versus net income of $37.3 million a year earlier, and adjusted diluted EPS fell to $0.82 from $1.00. The company also introduced 2025 guidance of $1.5 billion to $1.6 billion in revenue and $410 million to $450 million in adjusted EBITDA.
Full year 2024 revenue was $860.2 million, compared with $763.8 million in 2023
Full year 2024 GAAP net loss was $110.3 million, including $130.5 million of expenses tied to the Sterling acquisition
Full year 2024 adjusted diluted EPS was $0.82, compared with $1.00 in 2023
2025 guidance: revenue $1.5 billion to $1.6 billion; adjusted EBITDA $410 million to $450 million; adjusted diluted EPS $0.86 to $1.03
Acushnet reported full-year 2024 net sales of $2.46 billion, up 3.2%, and net income attributable to the company of $214.3 million, up $15.9 million, with fourth-quarter net loss narrowing to $1.1 million from $26.8 million a year earlier. The company also gave a 2025 outlook of $2.49 billion to $2.54 billion in net sales and $405 million to $420 million in Adjusted EBITDA, and raised its quarterly dividend 9.3% and added a $250.0 million share repurchase authorization.
Full-year 2024 Adjusted EBITDA was $404.4 million, up 7.5%, and fourth-quarter Adjusted EBITDA was $12.4 million versus a $1.5 million loss a year earlier
2025 outlook calls for net sales of $2,485 million to $2,535 million and Adjusted EBITDA of $405 million to $420 million, including an estimated negative currency impact of about $35 million
Quarterly cash dividend increased 9.3% to $0.235 per share, payable March 21, 2025 to holders of record as of March 7, 2025
On February 13, 2025, the board authorized an additional $250.0 million in share repurchases, bringing the total authorization to $1.25 billion
VSE reported fourth-quarter and full-year 2024 results, with revenue up 27% in the quarter and 26% for the year, while full-year GAAP diluted EPS fell 33% to $2.03. The company gave 2025 guidance only for its Aviation segment, withholding Fleet guidance because of the pending sale of that segment to One Equity Partners for up to $230 million. The filing also names Ben Thomas as chief operating officer and says Chief Legal Officer Farinaz Tehrani will resign effective March 28, 2025.
Q4 2024 revenue was $299.0 million, up 27%; GAAP diluted EPS was $0.77, down 6%; adjusted diluted EPS was $0.90, up 6%.
Full-year 2024 revenue was $1,080.1 million, up 26%; GAAP diluted EPS was $2.03, down 33%; adjusted diluted EPS was $3.13, down 5%.
2025 Aviation guidance: revenue growth of 35% to 40% and Adjusted EBITDA margin of 15.5% to 16.5%; no Fleet guidance due to the pending sale.
Ben Thomas appointed Chief Operating Officer effective immediately; Farinaz Tehrani to resign as Chief Legal Officer effective March 28, 2025.
Bristow Group reported fourth quarter and full-year 2024 results. Full-year net income rose to $94.8 million and Adjusted EBITDA of $236.8 million beat the top of its raised outlook, while fourth-quarter revenue fell from the prior quarter. The company also set a new $125 million share repurchase program, plans a quarterly dividend starting in Q1 2026, and intends to reduce gross debt to about $500 million by the end of 2026.
Full-year 2024 net income was $94.8 million, or $3.21 per diluted share, compared with a net loss of $6.8 million in 2023; total revenues were $1.4 billion versus $1.3 billion.
Fourth-quarter 2024 revenues were $353.5 million, down from $365.1 million in the third quarter, while diluted earnings per share rose to $1.07 from $0.95.
Full-year 2024 Adjusted EBITDA was $236.8 million, above the previously upward revised outlook range of $220 million to $230 million.
The company issued 2025 guidance of $1.420 billion to $1.615 billion in total revenues and $230 million to $260 million in Adjusted EBITDA, and plans a $0.125 per share quarterly dividend beginning in Q1 2026.
Innovex reported fourth-quarter 2024 revenue of $251 million, up 89% year-over-year, and adjusted EBITDA of about $49 million, up $17 million from a year earlier, with the Dril-Quip merger and DWS acquisition driving the gains. The board authorized a $100 million share repurchase program, and the company guided first-quarter 2025 adjusted EBITDA to $45 million to $50 million and revenue to $245 million to $255 million.
Q4 2024 revenue was $251 million, up 89% year-over-year and 65% sequentially; full-year 2024 revenue was $661 million, up 19%.
Q4 2024 adjusted EBITDA was about $49 million; free cash flow was $29 million.
Board authorized a $100 million share repurchase program.
Q1 2025 guidance: adjusted EBITDA of $45 million to $50 million and revenue of $245 million to $255 million.
Ovintiv reported a fourth-quarter 2024 net loss of $60 million, or $0.23 per diluted share, including a $350 million after-tax non-cash impairment. Full-year 2024 net earnings were $1.1 billion, or $4.21 per diluted share, down from $2.1 billion in 2023, and the Board declared a $0.30 quarterly dividend per share.
Q4 2024 net loss of $60 million, or $0.23 per diluted share, including a $350 million after-tax non-cash ceiling test impairment
Full-year 2024 net earnings of $1.1 billion, or $4.21 per diluted share, versus $2.1 billion ($7.90 per diluted share) in 2023
Full-year 2024 Non-GAAP Free Cash Flow of $1.7 billion; 2025 capital program of $2.15 to $2.25 billion
Quarterly dividend of $0.30 per share, payable March 31, 2025, to holders of record on March 14, 2025
Albany International reported fourth-quarter 2024 net revenues of $286.9 million, down 11.3% from a year earlier, and net income attributable to the company of $17.7 million ($0.56 per share) versus $30.5 million ($0.97 per share). The board also authorized a share repurchase program of up to $250 million, and the company gave initial 2025 guidance including total revenue of $1.165 to $1.265 billion and diluted EPS of $3.00 to $3.40.
Q4 2024 net revenues were $286.9 million, down 11.3%; adjusted EBITDA was $50.0 million, down 33.4% from $75.0 million
Full-year 2024 net revenues were $1.23 billion, up from $1.15 billion; full-year diluted EPS was $2.80 versus $3.55 in 2023
Board authorized a new share repurchase program of up to $250 million, superseding the current program
Initial 2025 guidance: total revenue of $1.165 to $1.265 billion, total adjusted EBITDA of $240 to $260 million, diluted EPS of $3.00 to $3.40
FirstEnergy reported full-year 2024 GAAP earnings from continuing operations of $978 million, or $1.70 per share, down from $1.96 in 2023, on revenue of $13.5 billion, up from $12.9 billion. Core (non-GAAP) earnings rose 8% to $2.37 per share, and the company introduced 2025 Core earnings guidance of $2.40 to $2.60 per share and a targeted 6-8% compound annual Core earnings growth rate through the five-year planning period. The GAAP decline reflects $0.93 per share in special items.
Full-year 2024 GAAP EPS was $1.70, versus $1.96 in 2023; Operating (non-GAAP) EPS was $2.63, versus $2.56.
Fourth-quarter 2024 GAAP EPS was $0.45, versus $0.30 a year earlier; Core EPS was $0.61, versus $0.52.
2025 Core EPS guidance is $2.40 to $2.60 per share, representing 5.5% growth at the midpoint over 2024 Core earnings.
Energize365 is extended through 2029 with a base capital investment plan of $28 billion, an 8% increase over the prior five-year program.
Encore Capital Group reported a full-year 2024 GAAP net loss of $139.2 million, or $5.83 per share, compared with a loss of $206.5 million in 2023, while full-year revenue rose 8% to $1.32 billion. Fourth-quarter results included a $100.6 million goodwill impairment and other Cabot-related charges tied to exiting Spanish and Italian non-performing loan markets, and the company said it expects 2025 collections to rise 11% to $2.4 billion and plans to resume share repurchases in 2025.
Full-year 2024 revenue of $1.32 billion, up 8% from 2023; fourth-quarter revenue of $265.6 million, down 4%
Fourth-quarter GAAP net loss of $225.3 million, or $9.42 per share, including $262.2 million in Cabot-related and other charges
Full-year 2024 collections rose 16% to $2.16 billion; 2025 collections are expected to increase 11% to $2.4 billion
Pure Storage reported fiscal fourth-quarter 2025 revenue of $879.8 million, up 11% year over year, and full-year revenue of $3.2 billion, up 12%. GAAP operating income and diluted EPS for the quarter fell from a year earlier, and the company guided fiscal 2026 revenue to $3.515 billion, up 11%, while its audit committee approved up to $250 million in additional share repurchases.
Q4 revenue $879.8 million, up 11% from $789.8 million a year earlier; full-year revenue $3.2 billion, up 12%.
Q4 GAAP operating income $42.5 million versus $57.4 million a year earlier; Q4 diluted EPS $0.12 versus $0.20.
FY26 guidance: revenue $3.515 billion, up 11%; non-GAAP operating income $595 million, a 17.0% margin.
Audit Committee approved up to an additional $250 million in share repurchases; Q4 repurchases totaled about $192 million.
MYR Group reported fourth-quarter 2024 revenue of $829.8 million, down 17.4% from a year earlier, and net income of $16.0 million, or $0.99 per diluted share, versus $1.43 a year earlier. For full-year 2024, revenue fell 7.7% to $3.36 billion and net income fell to $30.3 million, or $1.83 per diluted share, from $5.40 in 2023. The board also approved a $75.0 million share repurchase program that expires on September 5, 2025, which the company intends to fund with cash on hand and credit facility borrowings.
Q4 2024 revenue was $829.8 million, down $174.4 million from Q4 2023; net income was $16.0 million, or $0.99 per diluted share, versus $1.43
Full-year 2024 revenue was $3.36 billion, down 7.7%; net income was $30.3 million, or $1.83 per diluted share, versus $5.40 in 2023
Backlog was $2.58 billion at December 31, 2024, compared with $2.60 billion at September 30, 2024
Repurchase program authorizes up to $75.0 million of common stock through September 5, 2025, or until funds are exhausted
EMCOR reported record fourth-quarter and full-year 2024 revenues, diluted EPS and operating income, with fourth-quarter revenue up 9.6% to $3.77 billion and diluted EPS of $6.32. The company guided 2025 diluted EPS to $22.25 to $24.00 and increased its share repurchase authorization by $500 million.
Q4 2024 diluted EPS of $6.32 versus $4.47 a year earlier; full-year 2024 diluted EPS of $21.52 versus $13.31
Full-year 2024 revenues of $14.57 billion, up 15.8%; operating income of $1.34 billion, or 9.2% of revenues
2025 guidance: revenues of $16.1 billion to $16.9 billion, operating margin of 8.5% to 9.2%, diluted EPS of $22.25 to $24.00
Board authorized an additional $500 million for share repurchases under the existing program, which has no expiration date
Par Pacific reported a fourth-quarter 2024 net loss of $55.7 million, or $1.01 per diluted share, compared with net income of $289.3 million, or $4.77 per diluted share, a year earlier. For full year 2024, the company posted a net loss of $33.3 million, versus net income of $728.6 million in 2023, and Adjusted EBITDA fell to $238.7 million from $696.2 million. The company also said its Wyoming refinery has been idled since a February 12, 2025 operational incident and is expected to restart in mid-April at reduced throughput.
Q4 2024 revenues were $1.83 billion, down from $2.18 billion in Q4 2023
Full year 2024 net loss of $33.3 million, or $0.59 per diluted share, versus net income of $728.6 million in 2023
Repurchased 5 million common shares in 2024, or 9% of year-end shares outstanding
Wyoming refinery restart expected in mid-April 2025 at reduced throughput, with full operations by end of May
Graham Holdings reported fourth-quarter 2024 revenue of $1.2 billion, up 7%, and diluted earnings per share of $125.55, compared with $11.72 a year earlier. The EPS figure includes a one-time, noncash $653.4 million pension settlement gain; excluding certain items, fourth-quarter EPS was $22.58 versus $10.94. On February 25, 2025, the company also agreed to settle a significant portion of a mandatorily redeemable noncontrolling interest for $205 million.
Q4 2024 revenue was $1,245.8 million, up 7% from $1,166.8 million; operating income was $72.5 million versus $40.8 million.
Q4 diluted EPS was $125.55 versus $11.72; excluding certain items, EPS was $22.58 versus $10.94.
A $653.4 million pre-tax, noncash pension settlement gain was recorded in Q4 2024 after a group annuity purchase; the February 25, 2025 settlement totals $205 million, including $186.25 million in cash and $18.75 million in Class B stock.
Verisk reported fourth-quarter and full-year 2024 results, with revenue and per-share profit both higher than in the prior year, and gave 2025 guidance for revenue of $3,030 million to $3,080 million. The board also approved a 15% dividend increase and an additional $1.0 billion share repurchase authorization, which bear directly on shareholder returns.
Q4 2024 diluted EPS attributable to Verisk was $1.44, up 15.2%; diluted adjusted EPS was $1.61, up 15.0%.
Full-year 2024 revenue was $2,882 million, up 7.5%, and diluted EPS was $6.66, up 27.6%.
2025 guidance: revenue of $3,030 million to $3,080 million and diluted adjusted EPS of $6.80 to $7.10.
Board approved a 45-cent quarterly dividend payable March 31, 2025, up 15%, and an additional $1.0 billion buyback authorization on February 19, 2025.
DT Midstream reported full-year 2024 Adjusted EBITDA of $969 million, up from $924 million in 2023, and raised its 2025 Adjusted EBITDA guidance to $1.095 billion to $1.155 billion. Reported net income for 2024 was $354 million, or $3.60 per diluted share, down from $384 million in 2023, and the board raised the quarterly dividend 12% to $0.82 per share.
Full-year 2024 Adjusted EBITDA was $969 million, compared with $924 million in 2023.
Reported net income was $354 million, or $3.60 per diluted share, versus $384 million in 2023.
2025 Adjusted EBITDA guidance raised to $1.095 billion to $1.155 billion; 2026 early outlook is $1.155 billion to $1.225 billion.
Quarterly dividend of $0.82 per share, payable April 15, 2025 to stockholders of record on March 17, 2025.
Enovis reported fourth-quarter 2024 net sales of $561 million, up 23% on a reported basis, and adjusted earnings of $0.98 per diluted share, compared with $0.79 a year earlier. A $645 million non-cash goodwill impairment charge produced a fourth-quarter net loss from continuing operations of $704 million. The company also gave 2025 guidance of $2.19-2.22 billion in revenue and $3.10-3.25 in adjusted earnings per share, and CEO Matt Trerotola said he intends to retire once a successor is appointed.
Q4 2024 net sales $561 million, up 23% reported and 6% on a Comparable Sales basis
Q4 2024 net loss from continuing operations $704 million, including a $645 million goodwill impairment charge
Full-year 2024 net sales $2.1 billion, up 23%; full-year net loss from continuing operations $827 million
2025 outlook: revenue $2.19-2.22 billion, adjusted EBITDA $405-415 million, adjusted EPS $3.10-3.25; CEO Matt Trerotola plans to retire upon successor appointment
National Vision reported fourth-quarter 2024 net revenue of $437.3 million, up 3.9%, but a net loss from continuing operations of $(29.4) million, which the company attributed largely to a non-cash goodwill impairment charge. For fiscal 2024, revenue rose 3.8% to $1,823.3 million, while the net loss was $(27.2) million, compared with net income of $3.5 million in fiscal 2023, and adjusted diluted EPS rose to $0.52 from $0.47. The company also gave fiscal 2025 guidance, including adjusted diluted EPS of $0.52 to $0.64.
Q4 2024 net loss from continuing operations was $(29.4) million, versus $(14.7) million in Q4 2023; diluted EPS was $(0.37), versus $(0.19)
Q4 2024 adjusted diluted EPS was $(0.04), unchanged from Q4 2023; adjusted operating income rose to $3.2 million from $(2.7) million
Fiscal 2025 outlook (53 weeks ending January 3, 2026) includes net revenue of $1.901 billion to $1.955 billion and adjusted diluted EPS of $0.52 to $0.64
Cash balance was $73.9 million as of December 28, 2024; fiscal 2024 operating cash flow was $133.6 million
Clear Secure reported full-year 2024 revenue of $770.5 million, up 25.6%, and net income of $225.3 million, up from $49.9 million in 2023. The fourth-quarter results also include a one-time tax benefit. The company said President and CFO Kenneth Cornick will step down, with Michael Barkin named President and Jennifer Hsu named CFO, both effective March 31, 2025, and guidance calls for first-quarter 2025 revenue of $207-209 million.
Full-year 2024 operating income was $123.2 million, compared with $20.1 million in 2023.
Fourth-quarter 2024 net income of $116.6 million included a $165.5 million non-cash income tax benefit.
Kenneth Cornick resigns as President effective March 31, 2025, and remains CFO until his successor starts; Hsu, formerly of Chewy, becomes CFO effective March 31, 2025.
2025 guidance: first-quarter revenue of $207-209 million and full-year Free Cash Flow of at least $310 million.
ZoomInfo reported fourth-quarter 2024 revenue of $309.1 million, down 2% from a year earlier, and GAAP operating income of $30.9 million, down 56%. For full-year 2025 it guided to revenue of $1.185 billion to $1.205 billion, below 2024 revenue of $1.214 billion, while adjusted EPS guidance of $0.95 to $0.97 was roughly in line with 2024's $0.96. The board also approved an additional $500 million share repurchase authorization.
Q4 2024 GAAP revenue $309.1 million, down 2% year over year; GAAP diluted EPS $0.04 versus a $0.01 loss a year earlier
Full-year 2024 GAAP revenue $1,214.3 million, down 2%; GAAP diluted EPS $0.08 versus $0.27 in 2023
FY 2025 guidance: revenue $1.185 billion to $1.205 billion; adjusted EPS $0.95 to $0.97
Board approved an additional $500 million share repurchase authorization on February 21, 2025
Gulfport Energy reported a fourth-quarter and full-year 2024 net loss, driven by a $342.7 million impairment of oil and natural gas properties in the fourth quarter, after a profit in 2023. The company also gave 2025 guidance calling for flat total production and a 30%-plus increase in liquids output, with base capital spending of $370 million to $395 million.
Full-year 2024 net loss was $261.4 million, compared with net income of $1.47 billion in 2023; total revenues were $958.1 million, down from $1.79 billion.
Fourth-quarter 2024 net loss was $273.2 million, including a $342.7 million impairment; the same quarter of 2023 had net income of $245.7 million.
Full-year 2024 adjusted EBITDA was $731.1 million, which the company said was above analyst consensus expectations.
2025 guidance: net daily equivalent production of 1.04 to 1.065 Bcfe per day, described as flat, and net daily liquids production of 18.0 to 20.5 MBbl per day.
Grocery Outlet reported fourth-quarter fiscal 2024 net sales up 10.9% to $1.10 billion, but net income fell to $2.3 million, or $0.02 per diluted share, from $14.1 million, or $0.14, a year earlier. The company also issued fiscal 2025 guidance, announced a restructuring plan with $52 million to $61 million in expected total costs, and named Jason Potter as President and CEO.
Q4 net sales rose 10.9% to $1.10 billion; gross margin fell to 29.5% from 30.2%, and net income was $2.3 million versus $14.1 million a year earlier.
Fiscal 2025 outlook: net sales of $4.7 billion to $4.8 billion, adjusted EBITDA of $260 million to $270 million, and adjusted diluted EPS of $0.70 to $0.75.
Restructuring plan expected to cost $52 million to $61 million, of which $36 million to $45 million is cash; it includes terminating leases for 15 stores planned for fiscal 2025 and eight for fiscal 2026.
Jason Potter, who has over 30 years of industry experience and most recently led The Fresh Market, is the new President and CEO.
Innovex International reported fourth-quarter 2024 revenue of $251 million, up from $152 million in the third quarter and $133 million a year earlier, and net income of $32 million, compared with $18 million a year earlier. The company also gave first-quarter 2025 revenue guidance of $245 million to $255 million and Adjusted EBITDA guidance of $45 million to $50 million, and its board approved a new $100 million share repurchase program.
Q4 2024 revenue of $251 million, up 65% from Q3 2024 and up from $133 million in Q4 2023; full-year 2024 revenue was $661 million
Q4 2024 net income of $32 million, down from $83 million in Q3 2024 but up from $18 million in Q4 2023; full-year net income was $140 million
Q1 2025 guidance: total revenue of $245 million to $255 million and Adjusted EBITDA of $45 million to $50 million
Board approved a new share repurchase program of up to $100 million on February 25, 2025, replacing prior Dril-Quip plans
Sempra reported full-year 2024 GAAP earnings of $2.82 billion, or $4.42 per diluted share, down from $3.03 billion, or $4.79, in 2023, while adjusted earnings rose to $2.97 billion, or $4.65 per share, from $2.92 billion, or $4.61. The company revised its 2025 EPS guidance to $4.30 to $4.70, issued 2026 guidance of $4.80 to $5.30, and raised its five-year capital plan to $56 billion, which matters to shareholders because it sets the outlook for earnings and investment.
Full-year 2024 GAAP EPS was $4.42 versus $4.79 in 2023; adjusted EPS was $4.65 versus $4.61, and a $330 million foreign tax credit valuation allowance charge weighed on GAAP results
Fourth-quarter 2024 GAAP EPS was $1.04 versus $1.16; adjusted EPS was $1.50 versus $1.13
2025 EPS guidance revised to $4.30 to $4.70; 2026 EPS guidance of $4.80 to $5.30; long-term EPS growth rate raised to 7% to 9%
Quarterly common dividend declared at $0.645 per share, payable April 15, 2025, an annualized $2.58 per share versus $2.48 in 2024
Public Service Enterprise Group reported full-year 2024 net income of $1.77 billion ($3.54 per share), down from $2.56 billion ($5.13 per share) in 2023, while non-GAAP operating earnings rose to $3.68 per share from $3.48. Operating revenues fell to $10.29 billion from $11.24 billion, and the company initiated 2025 non-GAAP operating earnings guidance of $3.94 to $4.06 per share, with a raised five-year capital spending plan that matters to shareholders for future earnings growth and dividends.
FY 2024 net income $1.77 billion ($3.54 per share) vs. $2.56 billion ($5.13) in FY 2023; non-GAAP operating EPS $3.68 vs. $3.48
FY 2024 operating revenues $10.29 billion vs. $11.24 billion in FY 2023
2025 non-GAAP operating earnings guidance of $3.94 to $4.06 per share; midpoint up about 9% over 2024
2025-2029 capital spending plan raised to $22.5 billion to $26 billion, up $3.5 billion from prior plan; indicative 2025 dividend $2.52 per share, up $0.12
NexPoint Residential Trust reported fourth-quarter 2024 net loss attributable to common stockholders of $26.9 million, or $1.06 per diluted share, compared with net income of $18.4 million, or $0.70 per share, a year earlier. The company also issued initial 2025 guidance calling for a full-year loss of $1.05 to $1.33 per diluted share and Core FFO of $2.56 to $2.83 per diluted share, which shareholders should weigh against 2024 results of $0.04 per share in earnings and $2.79 per share in Core FFO.
Q4 2024 total revenues were $63.8 million, down from $68.9 million in Q4 2023; Q4 FFO was a loss of $6.5 million, or $0.25 per diluted share.
Full-year 2024 net income attributable to common stockholders was $1.1 million, or $0.04 per diluted share, versus $44.3 million, or $1.69 per diluted share, in 2023.
2025 guidance: earnings per diluted share of $(1.33) to $(1.05); Core FFO per diluted share of $2.56 to $2.83, with a midpoint of $2.70 versus $2.79 in 2024.
Same Store NOI guidance for 2025 ranges from -3.5% to 0.5%, with a midpoint of -1.5%.
Elanco reported fourth-quarter 2024 revenue of $1,020 million, down 1% on a reported basis, and a reported net loss of $8 million, narrower than the $141 million loss a year earlier. For 2025, it guided to adjusted EBITDA of $830 million to $870 million and adjusted EPS of $0.80 to $0.86, both below 2024 levels of $910 million and $0.91, citing about $45 million of foreign exchange headwind to adjusted EBITDA.
Q4 2024 revenue $1,020 million, down 1% reported and up 4% organic constant currency; Q4 adjusted EPS $0.14 vs. $0.08 a year earlier
Full-year 2024 reported net income $338 million vs. a $1,231 million loss in 2023; full-year revenue $4,439 million, flat reported
2025 guidance: revenue $4,445 million to $4,510 million, reported net (loss) income $(25) million to $7 million, adjusted EBITDA $830 million to $870 million
2025 guidance reflects about $110 million revenue and $45 million adjusted EBITDA foreign exchange headwinds; innovation revenue target raised to $640 million to $720 million
Integra LifeSciences reported fourth-quarter 2024 revenue of $442.6 million, up 11.5% on a reported basis but up 3.5% on an organic basis, and adjusted earnings of $0.97 per diluted share versus $0.89. For full-year 2024 it posted a GAAP net loss of $6.9 million, or $(0.09) per diluted share, and adjusted earnings per share fell to $2.56 from $3.10, with 2025 adjusted EPS guided to $2.41 to $2.51.
Q4 2024 revenue $442.6 million, up 11.5% reported and 3.5% organic; GAAP EPS $0.25 in both Q4 2024 and Q4 2023
Full-year 2024 GAAP net loss $6.9 million, or $(0.09) per diluted share, versus GAAP net income of $67.7 million, or $0.84, in 2023
Full-year 2024 adjusted EBITDA $322.2 million, down $47.4 million; 2025 revenue guidance $1,650 million to $1,715 million
Q1 2025 adjusted EPS guidance $0.40 to $0.45; full-year 2025 adjusted EPS guidance $2.41 to $2.51
Cleveland-Cliffs reported a full-year 2024 GAAP net loss of $708 million, or $1.57 per diluted share, compared with 2023 net income of $450 million, as revenue fell to $19.2 billion from $22.0 billion. CEO Lourenco Goncalves blamed weak steel demand and unsustainably low steel prices from imports, and said the fourth quarter should be the trough. The filing gives 2025 expectations that now include Stelco, but no 2025 revenue or earnings forecast.
Full-year 2024 revenues were $19.2 billion, down from $22.0 billion in 2023.
Full-year 2024 GAAP net loss was $708 million ($1.57 per diluted share), versus 2023 net income of $450 million ($0.78 per diluted share).
Fourth-quarter 2024 GAAP net loss was $434 million ($0.92 per diluted share); Adjusted EBITDA was a $81 million loss, versus $279 million a year earlier.
2025 expectations include capital expenditures of approximately $700 million and steel unit cost reductions of approximately $40 per net ton versus 2024.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.